The Canadian COVID‑19 Funded Research Database

Université de Sherbrooke

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 91 through 100 of 152 results (Download Results)

Show results per page

Development of a rapid and simple test to detect the COVID‑19 variants that can be used in remote areas and developing countries.

Tremblay, Jacques P | Université Laval | Operating Grant | $199,125

CIHR Quebec 2021

COVID-19 Variant Supplement – SARS-CoV-2 immunization strategies to enhance protective immunity with reduced risk of antibody-dependent enhancement (ADE)

Archambault, Denis | Université du Québec à Montréal | Operating Grant | $50,000

CIHR Quebec 2021

Substance use disorder treatment transformations due to the COVID‑19 pandemic: Impact on Indigenous patients and communities

Wendt, Dennis C | McGill University | Operating Grant | $167,124

CIHR Quebec 2020

Better understanding physical and cognitive impairments and functional limitations in people suffering from long COVID to support the development of adapted interventions

Roy, Jean-Sébastien | Université Laval | Operating Grant | $293,100

CIHR Quebec 2021

COVID-19 Variant Supplement – Development of a nanoparticle-based vaccine candidate to the SARS-CoV-2

Leclerc, Denis | CHU de Québec | Operating Grant | $50,000

CIHR Quebec 2021

A cell-based assay to measure immune competence in SARS-CoV-2 infection and vaccination

De Serres, Sacha | Université Laval | Operating Grant | $246,164

CIHR Quebec 2021

COVID-19 Variant Supplement – Early immune predictors of sustained SARS-CoV-2 antibody responses after COVID‑19 disease

Kaufmann, Daniel E | Centre hospitalier de l'Université de Montréal | Operating Grant | $50,000

CIHR Quebec 2021

Identification of microbial factors to modulate immune dysregulation and treat post-COVID-19 syndrome.

Falcone, Emilia L | Institut de recherches cliniques de Montréal | Operating Grant | $493,955

CIHR Quebec 2021

COVID-19 Variant Supplement – Preventing SARS-CoV-2 infection by targeting human type II transmembrane serine protease activity

Leduc, Richard | Université de Sherbrooke | Operating Grant | $50,000

CIHR Quebec 2021

Évaluation en temps réel du déploiement de technologies connectées et du partenariat de soins et services dans le contexte de crise sanitaire lié à la COVID‑19 – le programme Techno-COVID-Partenariat

Pomey, Marie-Pascale A | Centre hospitalier de l'Université de Montréal | Operating Grant | $502,487

CIHR Quebec 2020

The Canadian COVID‑19 Funded Research Database

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

Development of a rapid and simple test to detect the COVID‑19 variants that can be used in remote areas and developing countries.

COVID-19 Variant Supplement – SARS-CoV-2 immunization strategies to enhance protective immunity with reduced risk of antibody-dependent enhancement (ADE)

Substance use disorder treatment transformations due to the COVID‑19 pandemic: Impact on Indigenous patients and communities

Better understanding physical and cognitive impairments and functional limitations in people suffering from long COVID to support the development of adapted interventions

COVID-19 Variant Supplement – Development of a nanoparticle-based vaccine candidate to the SARS-CoV-2

A cell-based assay to measure immune competence in SARS-CoV-2 infection and vaccination

COVID-19 Variant Supplement – Early immune predictors of sustained SARS-CoV-2 antibody responses after COVID‑19 disease

Identification of microbial factors to modulate immune dysregulation and treat post-COVID-19 syndrome.

COVID-19 Variant Supplement – Preventing SARS-CoV-2 infection by targeting human type II transmembrane serine protease activity

Évaluation en temps réel du déploiement de technologies connectées et du partenariat de soins et services dans le contexte de crise sanitaire lié à la COVID‑19 – le programme Techno-COVID-Partenariat